You may be wondering about the benefits medical telemarketing can bring to a company? Well, if you are targeting the...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
ALLERGAN INC.
Allergan, Inc. is a global, multi-specialty healthcare company that operates in two business segments: specialty pharmaceuticals and medical devices. Their products include ophthalmic pharmaceuticals, dermatology products, and neurological products. Allergan, Inc.’s most notable product is Botox, which is used for therapeutic and aesthetic indications. The company was founded in 1948 and is headquartered in Irvine, California.
Allergan Inc. is part of Business Exchange, suggested by
Ulli Muenker.
This topic contains
244 news
and
82 blog
items.
Read updated news, blogs, and resources about Allergan Inc.. Find user-submitted articles and reactions on Allergan Inc. from
like-minded professionals.
Most Active
The most active stories in this topic based on user activity.
As Botox sales continue to dive, Allergan Inc. chief executive David Pyott is feeling the pressure from doctors who...
No Surprise: Device Maker TherOx Nixes Initial Public Offering as Bear Market Continues
NYSE:SNY) and Novartis, but we should not rule out (NYSE: JNJ) or GlaxoSmithKline, if its acquisition of Allergan Inc.
Updated Date: Aug 14, 2009 EST...
Updated Date: Feb 19, 2009 EST...
Allergan Inc. launched its first-ever consumer rebate for the antiwrinkle drug Botox, as the company posted a 6.
Emulsion treatment leads to improved quality of life and favorable cost-effectiveness ratios
Allergan Inc. plans to cut 460 jobs, about five percent of its workforce, as it announced a smaller fourth quarter...
Top Sources: Allergan Inc.
- grinza.com
- Reuters
- MarketWatch
- TheDeal.com
- ocbj.com
- realself.com
- BusinessWeek
- DailyMed Drug Label Updates for the last seven days (since Feb 12, 2009 EST)
- Wall Street Journal Online
- DailyMed Drug Label Updates for the last seven days (since Aug 8, 2009 EST)
account